KRAS and neoplasm: However, there are undoubtedly other indirect mechanisms driving RAS oncogenic activity in KRAS wt tumours, such as epigenetic regulation, inter-exonic variants, influence of the tumour microenvironment and growth factor expression, negative feedback loop regulation, metabolic regulation or others.